KAPA

KAIROS PHARMA LTD

• TipRanks·5d ago

  Kairos Pharma announces interim safety data from Phase 1 trial of ENV-105

• TipRanks·06/30 21:50

  Kairos Pharma Shareholders Approve Reverse Split, Governance Measures

• TipRanks·06/04 12:37

  Kairos Pharma outlines mid-year oncology pipeline and funding plans

• TipRanks·06/04 12:18

  Kairos Pharma issues letter from CEO that recaps year, details plans for 2026

• NASDAQ·06/03 13:10

  Pre-Market Movers: PMI, CNTB, RNAZ Chart The Course

• TipRanks·05/18 13:27

  Kairos Pharma Highlights Clinical Programs at LD Micro

• TipRanks·05/14 15:50

  Analysts Offer Insights on Healthcare Companies: Kairos Pharma, Ltd. (KAPA), Integra Lifesciences (IART) and Biogen (BIIB)

• TipRanks·04/03 07:10

  Analysts Are Bullish on Top Healthcare Stocks: Kairos Pharma, Ltd. (KAPA), Actinium Pharmaceuticals (ATNM)

• TipRanks·03/11 11:05

  Expanding Lung Cancer Franchise and Strategic Asset Acquisition Support Buy Rating on Kairos Pharma

• TipRanks·03/11 11:00

  Analysts’ Opinions Are Mixed on These Healthcare Stocks: Kairos Pharma, Ltd. (KAPA), Pfizer (PFE) and Medtronic (MDT)

• TipRanks·03/02 12:19

  Kairos Pharma Acquires Rights to AI-Discovered EGFR Therapy

• TipRanks·03/02 11:53

  Kairos Pharma to acquire CL-273 from Celyn Therapeutics

• NASDAQ·02/27 14:17

  Weekly Buzz: MGNX's LINNET Trial On Hold; ETON, ALUR Get FDA Nod; GILD Snaps Up ACLX

• NASDAQ·02/27 01:53

  Kairos Pharma Signs Term Sheet To Acquire Two Oncology Assets From Celyn Therapeutics; Stock Up

• TipRanks·02/26 14:24

  Kairos Pharma to acquire to two clinical-stage oncology assets from Celyn